Back to search results

Observational Study of Remote Symptom Monitoring for Cancer Patients

This study is looking at the real-world experiences of people with breast, lung, ovarian, multiple myeloma, or acute myelogenous leukemia (a type of blood cancer) who are using a remote symptom monitoring system called Carevive. The goal is to collect information through weekly online surveys about your symptoms and how you're doing while on active cancer treatment. This information will help build a large dataset to better understand how this system works in routine care. You can join if you are 18 or older, have one of these cancers, and can complete online surveys in English using your own device. The study aims to create a data set over one year.

Study design
This is an observational study, meaning researchers will collect information without giving new treatments. It plans to include 25 participants.
What's involved
You will complete a baseline survey and then weekly online surveys for at least 12 weeks, and potentially longer if you continue treatment.
Compensation
Not stated in the trial record.
Follow-up
The primary goal is to create a data set measured at 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05974150

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Recruiting
Not specifiedAges 18+Observational
Carevive Systems, Inc.
~25 participants
Updated 2026-02-23 on ClinicalTrials.gov
What's tested:Web based survey

At a glance

Recruiting sites
4 of 7 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Create Data Set
Measured over 1 year

Conditions

Breast Cancer
Lung Cancer
Multiple Myeloma
Ovarian Cancer
Acute Myelogenous Leukemia

Explore related trials

Acute Myeloid LeukemiaBreast CarcinomaLung CarcinomaMalignant Ovarian NeoplasmMultiple Myeloma

Where it's being run

7 sites across 4 states
Ohio3
North Carolina2
Connecticut1
Illinois1

Who to contact

JULIE SCOTT, MSN
[email protected]
8778423210
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

All participants must be 18 years of age or older.
Subjects may be any stage and anywhere in the treatment continuum.
Subject participants must have a diagnosis of a breast, lung, AML, ovarian cancer or multiple myeloma.
Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer.
All participants must be able to understand English.

Exclusion

Any patient who cannot understand written or spoken English.
Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer.
Any patient on a treatment clinical trial.
Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).

What this trial measures

  • Create Data Set1 year

    The goal of this registry is to create a data set from real world clinical and patient reported data collected using an electronic care planning system (CPS) that is used in routine care for cancer patients on active treatment